ATE303153T1 - Ibandroinsäure zur förderung der osseointegration der endoprothesen - Google Patents

Ibandroinsäure zur förderung der osseointegration der endoprothesen

Info

Publication number
ATE303153T1
ATE303153T1 AT99958135T AT99958135T ATE303153T1 AT E303153 T1 ATE303153 T1 AT E303153T1 AT 99958135 T AT99958135 T AT 99958135T AT 99958135 T AT99958135 T AT 99958135T AT E303153 T1 ATE303153 T1 AT E303153T1
Authority
AT
Austria
Prior art keywords
ibandroic
endoprotheses
osseointegration
promote
acid
Prior art date
Application number
AT99958135T
Other languages
English (en)
Inventor
Frieder Bauss
Andreas A Kurth
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Application granted granted Critical
Publication of ATE303153T1 publication Critical patent/ATE303153T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
AT99958135T 1998-12-04 1999-11-29 Ibandroinsäure zur förderung der osseointegration der endoprothesen ATE303153T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19855976 1998-12-04
PCT/EP1999/009252 WO2000033849A1 (en) 1998-12-04 1999-11-29 Use of ibandronate for promoting osseointegration of endoprostheses

Publications (1)

Publication Number Publication Date
ATE303153T1 true ATE303153T1 (de) 2005-09-15

Family

ID=7889968

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99958135T ATE303153T1 (de) 1998-12-04 1999-11-29 Ibandroinsäure zur förderung der osseointegration der endoprothesen

Country Status (17)

Country Link
US (1) US6680307B1 (de)
EP (2) EP1614422A3 (de)
JP (1) JP3793023B2 (de)
KR (1) KR100453779B1 (de)
CN (1) CN1173704C (de)
AR (1) AR020017A1 (de)
AT (1) ATE303153T1 (de)
AU (1) AU756540B2 (de)
BR (1) BR9915927A (de)
CA (1) CA2353528C (de)
DE (1) DE69927048T2 (de)
DK (1) DK1135140T3 (de)
ES (1) ES2247842T3 (de)
PT (1) PT1135140E (de)
TR (1) TR200101546T2 (de)
WO (1) WO2000033849A1 (de)
ZA (1) ZA200104140B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002004038A1 (en) * 2000-07-12 2002-01-17 Hopital Orthopedique De La Suisse Romande Active biocoating for bone implant
BR0200291A (pt) * 2001-02-01 2003-07-01 Riderway Corp Composição farmacêutica lìquida para o uso no tratamento de doenças ósseas, processo para preparar a mesma e processo para tratamento de uma doença óssea
MXPA04006027A (es) * 2001-12-21 2004-09-27 Procter & Gamble Metodo para el tratamiento de trastornos de los huesos.
KR20140021045A (ko) * 2002-05-10 2014-02-19 에프. 호프만-라 로슈 아게 골다공증 치료 및 예방용 비스포스폰산
JP4427453B2 (ja) * 2002-12-20 2010-03-10 エフ．ホフマン−ラ ロシュ アーゲー 高用量イバンドロネート製剤
ES2561463T3 (es) * 2003-08-21 2016-02-26 Addbio Ab Dispositivo de implante recubierto con bisfosfonato y método para el mismo
CN101111505B (zh) * 2005-02-01 2011-09-14 霍夫曼-拉罗奇有限公司 伊班膦酸盐多晶型物b
ES2712644T3 (es) * 2005-02-01 2019-05-14 Atnahs Pharma Uk Ltd Uso médico del polimorfo A de Ibandronato
US8071574B2 (en) * 2005-02-22 2011-12-06 John Dennis Bobyn Implant improving local bone formation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3623397A1 (de) 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
JPH08505142A (ja) 1992-12-23 1996-06-04 メルク エンド カンパニー インコーポレーテッド 骨損失を治療及び予防するためのビスホスホネート／エストロゲン療法
US5403829A (en) 1993-03-24 1995-04-04 Leiras Oy Use of bisphosphonates in endo-osteal bone surgery
FI92465C (fi) 1993-04-14 1994-11-25 Risto Tapani Lehtinen Menetelmä endo-osteaalisten materiaalien käsittelemiseksi
US5646134A (en) 1994-04-21 1997-07-08 Merck & Co., Inc. Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices
GB9408775D0 (en) * 1994-05-04 1994-06-22 Ciba Geigy Ag Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
CA2223450A1 (en) * 1995-06-06 1996-12-12 Merck & Co., Inc. Bisphosphonate cement composition to prevent aseptic loosening of orthopedic implant devices
CA2274789A1 (en) * 1996-12-13 1998-06-18 Zymogenetics, Inc. Compositions and methods for stimulating bone growth

Also Published As

Publication number Publication date
CA2353528C (en) 2007-04-24
EP1135140A1 (de) 2001-09-26
CN1329495A (zh) 2002-01-02
EP1614422A2 (de) 2006-01-11
AU756540B2 (en) 2003-01-16
DK1135140T3 (da) 2005-12-19
KR20010093137A (ko) 2001-10-27
KR100453779B1 (ko) 2004-10-20
JP3793023B2 (ja) 2006-07-05
CA2353528A1 (en) 2000-06-15
AR020017A1 (es) 2002-03-27
AU1557700A (en) 2000-06-26
US6680307B1 (en) 2004-01-20
BR9915927A (pt) 2001-08-21
DE69927048D1 (de) 2005-10-06
EP1135140B1 (de) 2005-08-31
PT1135140E (pt) 2005-10-31
DE69927048T2 (de) 2006-06-08
ES2247842T3 (es) 2006-03-01
WO2000033849A1 (en) 2000-06-15
EP1614422A3 (de) 2009-02-18
ZA200104140B (en) 2002-08-21
CN1173704C (zh) 2004-11-03
JP2002531509A (ja) 2002-09-24
TR200101546T2 (tr) 2001-11-21

Similar Documents

Publication Publication Date Title
DE60026734D1 (de) Brücke zur can-tcp/ip-verbindung
DE60017336D1 (de) Zusammensetzung zur Herstellung von Harzen
CY2006003I2 (el) Χρηση δαπτομυκινης
DE69918278D1 (de) Substituierte indolalkansäure
ID27092A (id) Pembuatan ftalat anhidrida
ID22508A (id) Trokar untuk memasukkan implant-implant
DE60042550D1 (de) Mutierte varianten des insulin-ähnlichen wachstumsfaktor i (igf-i)
PT945132E (pt) Composicao de ibuprofeno
ATE399350T1 (de) System zur bestimmung der endgültigen position von zähnen
DE19983486T1 (de) Verfahren zur Herstellung von Citalopram
DE69805787D1 (de) Verbindungen zur hemmung der magensäuresekretion
DE69906389T2 (de) Verfahren zur herstellung von citalopram
DK1100769T3 (da) Aminomethylcarboxylsyrederivater
ATE401309T1 (de) Verwendung von 2-fuoro-3-ketoestern zur herstellung von 3-fuoro-6,7,8,9-tetrahydro-4h- pyrimidoä1,2-aüpyrimidin-4-onen
DE60019960D1 (de) Herstellung von isobutencopolymere
PT1240157E (pt) Derivados substituidos do acido n-benzil-indol-3-il-glioxalico com efeito antitumoral
DE60100858D1 (de) Prozess zur herstellung der kristallinen form i von cabergolin
ATE303153T1 (de) Ibandroinsäure zur förderung der osseointegration der endoprothesen
DE69928820D1 (de) Akt zusammensetzungen zur steigerung des überlebens von kardiomyozyten
DE69822711D1 (de) Verfarhen zur Herstellung von Dialkylnaphthalinen
DE69900514D1 (de) Herstellung von Polyalkylsilsesquioxan-Partikeln
DE50001739D1 (de) Parfüm mit möglichkeiten zur änderung der duftnote
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
DE69901243T2 (de) Artikulator zur herstellung von zahnärztlichen prothesen
DE69935355D1 (de) Verfahren zur Herstellung von Citalopram

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1135140

Country of ref document: EP